Afinitor™ approved by the US FDA for the treatment of noncancerous kidney tumors

被引：0
|
作者：
O'Hare, Alice
机构：
来源：
FUTURE ONCOLOGY | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [41] Repurposing of FDA approved drugs for treatment of metastatic HNSCC
    Kondratyev, Maria
    Pesic, Aleksandra
    Dvorkin-Sheva, Anna
    Ketela, Troy
    Moffat, Jason
    Koritzinsky, Marianne
    Wouters, Brad
    CANCER RESEARCH, 2020, 80 (16)
  • [42] Highlights on Fluorine-Containing Drugs Approved by US FDA in 2023
    Ali, Saghir
    Bolinger, Andrew A.
    Zhou, Jia
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 843 - 849
  • [43] Once-daily rilpivirine approved by the US FDA for HIV infection
    不详
    FUTURE VIROLOGY, 2011, 6 (07) : 791 - 791
  • [44] Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
    Kevin A. Scott
    Jon T. Njardarson
    Topics in Current Chemistry, 2018, 376
  • [45] Combination vaccine against a meningococcal and Hib diseases approved by US FDA
    O'Hare, Alice
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 886 - 886
  • [46] Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis
    Mascarenhas, John
    Hoffman, Ronald
    CLINICAL CANCER RESEARCH, 2012, 18 (11) : 3008 - 3014
  • [47] FDA: IVERMECTIN NOT APPROVED FOR COVID-19 TREATMENT
    不详
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2020, 256 (11): : 1189 - 1189
  • [48] First new therapy for lupus approved by the US FDA since 1955
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 263 - 263
  • [49] Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
    Scott, Kevin A.
    Njardarson, Jon T.
    TOPICS IN CURRENT CHEMISTRY, 2018, 376 (01)
  • [50] A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinoma
    Kash, Natalie
    Silapunt, Sirunya
    FUTURE ONCOLOGY, 2021, 17 (23) : 3111 - 3132
12345